BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37195744)

  • 1. Implication of COVID-19 pandemic on the incidence of
    Karampatakis T; Tsergouli K; Kandilioti E; Nikopoulou A; Katsifa H; Kachrimanidou M
    J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195744
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.
    Maldonado-Barrueco A; Moreno-Ramos F; Díaz-Pollán B; Loeches-Yagüe B; Rico-Nieto A; García-Rodríguez J; Ruiz-Carrascoso G
    Anaerobe; 2024 Apr; 86():102836. PubMed ID: 38428802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
    Endo K; Mizuno K; Takeuchi M; Kawakami K
    Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare-associated
    Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
    Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
    Spigaglia P
    Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection.
    Merchante N; Chico P; Márquez-Saavedra E; Riera G; Herrero R; González-de-la-Aleja P; Aller AI; Rodríguez JC; Rodríguez-Fernández M; Ramos JM; Trigo-Rodríguez M; Merino E
    Anaerobe; 2022 Jun; 75():102579. PubMed ID: 35500744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre.
    Voona S; Abdic H; Montgomery R; Clarkson A; Twitchell H; Hills T; Briggs S; Crooks C; Monaghan TM
    Anaerobe; 2022 Feb; 73():102479. PubMed ID: 34801705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in facility-level rates of
    Rose AN; Baggs J; Kazakova SV; Guh AY; Yi SH; McCarthy NL; Jernigan JA; Reddy SC
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):238-245. PubMed ID: 35586888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial
    Ponce-Alonso M; Sáez de la Fuente J; Rincón-Carlavilla A; Moreno-Nunez P; Martínez-García L; Escudero-Sánchez R; Pintor R; García-Fernández S; Cobo J
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):406-410. PubMed ID: 32895065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis.
    Granata G; Petrosillo N; Al Moghazi S; Caraffa E; Puro V; Tillotson G; Cataldo MA
    Anaerobe; 2022 Apr; 74():102484. PubMed ID: 34843959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential causal effect of contact precautions and isolation on Clostridioides difficile infection in the hyperendemic setting: Interrupted time-series analyses before and after implementation.
    Lee EH; Lee HS; Lee KH; Song YG; Han SH
    J Microbiol Immunol Infect; 2023 Oct; 56(5):1054-1063. PubMed ID: 37380552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between consumption of antibiotics, infection control interventions and Clostridioides difficile infections: Analysis of six-year time-series data in a tertiary-care hospital in Greece.
    Papanikolopoulou A; Maltezou HC; Gargalianos-Kakolyris P; Pangalis A; Pantazis N; Pantos C; Tountas Y; Tsakris A; Kantzanou M
    Infect Dis Health; 2022 Aug; 27(3):119-128. PubMed ID: 35153189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.
    Birlutiu V; Dobritoiu ES; Lupu CD; Herteliu C; Birlutiu RM; Dragomirescu D; Vorovenci A
    Medicine (Baltimore); 2022 Jul; 101(27):e29823. PubMed ID: 35801777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
    Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Describing the monthly variability of hospital-onset
    Lang K; Atchison TJ; Singh P; Kline DM; Odei JB; Martin JL; Smyer JF; Day SR; Hebert CL
    Infect Control Hosp Epidemiol; 2024 Mar; 45(3):329-334. PubMed ID: 37807908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in
    Choi KB; Du T; Silva A; Golding GR; Pelude L; Mitchell R; Rudnick W; Hizon R; Al-Rawahi GN; Chow B; Davis I; Evans GA; Frenette C; Johnstone J; Kibsey P; Katz KC; Langley JM; Lee BE; Longtin Y; Mertz D; Minion J; Science M; Srigley JA; Stagg P; Suh KN; Thampi N; Wong A; Comeau JL; Hota SS;
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1180-1183. PubMed ID: 35978535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.
    Bentivegna E; Alessio G; Spuntarelli V; Luciani M; Santino I; Simmaco M; Martelletti P
    Am J Infect Control; 2021 May; 49(5):640-642. PubMed ID: 33031863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.